Document and Entity Information Document Information [Table] Class of Stock [Axis] Class of Stock [Domain] Common Stock [Member] Ordinary shares Ordinary Shares Represents the information pertaining to american depositary shares. American Depositary Shares [Member] American Depositary Shares Document Information [Line Items] Document Information Document Type Document Quarterly Report Document Transition Report Document Period End Date Entity File Number Entity Registrant Name Entity Incorporation, State or Country Code Entity Tax Identification Number Entity Address, Country Entity Address, Address Line One Entity Address, Address Line Two Entity Address, City or Town Entity Address, Postal Zip Code City Area Code Local Phone Number Title of 12(b) Security Trading Symbol Security Exchange Name Entity Current Reporting Status Entity Interactive Data Current Entity Filer Category Entity Small Business Entity Emerging Growth Company Entity Ex Transition Period Entity Shell Company Entity Common Stock, Shares Outstanding Entity Central Index Key Current Fiscal Year End Date Document Fiscal Year Focus Document Fiscal Period Focus Amendment Flag CONDENSED CONSOLIDATED BALANCE SHEETS Statement [Table] This member stands for deferred A shares Deferred A Shares. [Member] Deferred A shares Deferred A Shares Represents information pertaining to deferred B shares. Deferred B Shares [Member] Deferred B shares Deferred B Shares Represents information pertaining to deferred C shares. Deferred C Shares [Member] Deferred C shares Deferred C Shares Statement [Line Items] Statement Assets [Abstract] ASSETS Assets, Current [Abstract] Current assets: Cash and Cash Equivalents, at Carrying Value cash and cash equivalents Accounts Receivable, after Allowance for Credit Loss, Current Accounts receivable Due from Related Parties, Current Accounts receivable - related parties Amount of research and development incentives receivable. Research and Development Incentives Receivable Prepaid Expense and Other Assets, Current Prepaid expenses and other current assets Total Assets, Current Total current assets Goodwill Goodwill Property, Plant and Equipment, Net Property and equipment, net Intangible Assets, Net (Excluding Goodwill) Intangible assets, net Operating Lease, Right-of-Use Asset Right of use assets, net Right-of-use asset Other assets Other assets Assets Total assets Liabilities and Equity [Abstract] LIABILITIES AND SHAREHOLDERS' EQUITY Liabilities, Current [Abstract] Current liabilities: Accounts Payable, Current Accounts payable Amount of expenses incurred but not yet paid nor invoiced, and liabilities classified as other. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). Accrued Liabilities and Other Liabilities, Current Accrued expenses and other current liabilities Total Operating Lease, Liability, Current Operating lease liability, current Liabilities, Current Total current liabilities Liabilities, Noncurrent [Abstract] Non-Current liabilities: Operating Lease, Liability, Noncurrent Operating lease liability, non-current Business Combination, Contingent Consideration, Liability, Noncurrent Contingent consideration Amount of classified as non-current liabilities, net value of deferred tax liability. Deferred Tax Liability, Net Deferred tax liability, net Other Liabilities, Noncurrent Other non-current liabilities Liabilities Total liabilities Commitments and Contingencies. Commitments and contingencies Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest [Abstract] Shareholders' equity: Common Stock, Value, Issued Ordinary shares, £0.000025 nominal value; 38,357,025 shares authorized, issued and outstanding (December 31, 2022: authorized, issued and outstanding: 37,683,531) Aggregate par or stated value of issued deferred stock. Deferred Stock, Value Issued Deferred shares Additional Paid in Capital Additional paid-in capital Retained Earnings (Accumulated Deficit) Accumulated deficit Accumulated Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Net of Tax Accumulated other comprehensive loss - foreign currency translation adjustments Stockholders' Equity Attributable to Parent Total shareholders' equity attributable to Vaccitech plc shareholders' Stockholders' Equity Attributable to Noncontrolling Interest Noncontrolling interest Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest Balance at the end Balance at the beginning Total shareholders' equity Liabilities and Equity Total liabilities and shareholders' equity Common Stock, Par or Stated Value Per Share Ordinary shares, nominal value Common Stock, Shares Authorized Ordinary shares, authorized Common Stock, Shares, Issued Ordinary shares, issued Common Stock, Shares, Outstanding Ordinary shares, outstanding Face amount or stated value per share of deferred stock. Deferred Stock, Par Or Stated Value Per Share Deferred shares, nominal value Nominal value The maximum number of deferred shares permitted to be issued by an entity's charter and bylaws. Deferred Stock, Shares Authorized Deferred shares, authorized Total number of deferred shares of an entity that have been sold or granted to shareholders Deferred Stock, Shares Issued Deferred shares, issued Number of shares of deferred stock outstanding. Deferred Stock, Shares Outstanding Deferred shares, outstanding CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS Product and Service [Axis] Product and Service [Domain] License [Member] License revenue Information pertaining to research grants and contracts. Research Grants And Contracts [Member] Research grants and contracts Revenue from Contract with Customer, Excluding Assessed Tax Total revenue Operating Expenses [Abstract] Operating expenses Research and Development Expense Research and development General and Administrative Expense General and administrative Operating Expenses Total operating expenses Operating Income (Loss) (Loss)/income from operations Other Income and Expenses [Abstract] Other income/(expense): Investment Income, Interest Interest income Interest Expense Interest expense Represents the research and development incentives (expenses) for the period. Research And Development Incentive Income (Expense) Research and development incentives Nonoperating Income (Expense) Total other income/(expense) Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest (Loss)/profit before income tax Income Tax Expense (Benefit) Tax benefit Net Income (Loss), Including Portion Attributable to Noncontrolling Interest Net (loss)/income Net (loss)/income Net Income / (loss) Net Income (Loss) Attributable to Noncontrolling Interest Net loss attributable to noncontrolling interest Net Income (Loss) Attributable to Parent Net (loss)/income attributable to Vaccitech plc shareholders Weighted Average Number of Shares Outstanding, Basic Weighted-average ordinary shares outstanding, basic Weighted Average Number of Shares Outstanding, Diluted Weighted-average ordinary shares outstanding, diluted Weighted-average ordinary shares outstanding, diluted Earnings Per Share, Basic Net (loss)/income per share attributable to ordinary shareholders, basic Earnings Per Share, Diluted Net (loss)/income per share attributable to ordinary shareholders, diluted Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax Other comprehensive gain/(loss) - foreign currency translation adjustments Foreign currency translation adjustments Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest Comprehensive loss Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest Comprehensive loss attributable to noncontrolling interest Comprehensive Income (Loss), Net of Tax, Attributable to Parent Comprehensive loss attributable to Vaccitech plc shareholders Revenue from Related Parties Revenue from related party transactions Revenue from related parties CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY Equity Components [Axis] Equity Component [Domain] Represents information pertaining to deferred shares. Deferred Shares [Member] Deferred shares Deferred Shares Additional Paid-in Capital [Member] Additional Paid-in-capital Retained Earnings [Member] Accumulated Deficit AOCI Attributable to Parent [Member] Accumulated Other Comprehensive Loss Noncontrolling Interest [Member] Noncontrolling Interest Increase (Decrease) in Stockholders' Equity [Roll Forward] Increase (Decrease) in Stockholders' Equity Shares, Issued Balance at the end (in shares) Balance at the beginning (in shares) APIC, Share-based Payment Arrangement, Increase for Cost Recognition Share based compensation The value of deferred shares cancelled during the period. Shares Cancelled During Period, Value, Deferred Shares Cancellation of deferred shares The number of deferred shares cancelled during the period. Shares Cancelled During Period, Shares, Deferred Shares Cancellation of deferred shares (in shares) Stock Issued During Period, Value, Other Issue of ordinary shares Stock Issued During Period, Shares, Other Issue of ordinary shares (in shares) CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS Net Cash Provided by (Used in) Operating Activities [Abstract] CASH FLOWS FROM OPERATING ACTIVITIES: Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract] Adjustments to reconcile net income / (loss) to net cash used in operating activities: Share-based Payment Arrangement, Noncash Expense Share based compensation Depreciation, Depletion and Amortization Depreciation and amortization The amount of non-cash lease expenses. Non-Cash Lease Expenses Non-cash lease expenses Foreign Currency Transaction Gain (Loss), Unrealized Non-cash gain on foreign currency remeasurement and other non-cash adjustments Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability Change in contingent consideration Deferred Income Tax Expense (Benefit) Deferred tax benefit Other Noncash Income (Expense) Other non-cash expenses Increase (Decrease) in Operating Capital [Abstract] Changes in operating assets and liabilities: Increase (Decrease) in Accounts Receivable Accounts receivable (including related parties) Increase (Decrease) in Prepaid Expense and Other Assets Prepaid expenses and other current assets Amount of increase (decrease) in research and development incentives receivable. Increase (Decrease) in Research and Development Incentives Receivable Research and development incentives receivable Increase (Decrease) in Accounts Payable Accounts payable Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities Accrued expenses and other current liabilities Increase (Decrease) in Contract with Customer, Liability Deferred revenue Increase (Decrease) in Other Operating Assets Other assets Net Cash Provided by (Used in) Operating Activities Net cash used in operating activities Net Cash Provided by (Used in) Investing Activities [Abstract] CASH FLOWS FROM INVESTING ACTIVITIES: Payments to Acquire Property, Plant, and Equipment Purchases of property and equipment Net Cash Provided by (Used in) Investing Activities Net cash used in investing activities Net Cash Provided by (Used in) Financing Activities [Abstract] CASH FLOWS FROM FINANCING ACTIVITIES: Proceeds, Issuance of Shares, Share-based Payment Arrangement, Including Option Exercised Issue of shares from the exercise of stock options Proceeds from Issuance of Common Stock Proceeds from issue of ordinary shares Payment for Contingent Consideration Liability, Financing Activities Payment of contingent consideration Repayments of Short-term Debt Repayment of debt Net Cash Provided by (Used in) Financing Activities Net cash provided by/(used in) financing activities Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations EFFECT OF EXCHANGE RATES ON CASH AND CASH EQUIVALENTS Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect Net (decrease) in cash and cash equivalents Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents Cash and cash equivalents, end of the period Cash and cash equivalents, beginning of the period Supplemental Cash Flow Information [Abstract] Supplemental cash flow disclosures: Interest Paid, Excluding Capitalized Interest, Operating Activities Cash paid for interest Income Taxes Paid, Net Cash paid for income taxes Non-Cash investing and financing activities Stock Issued Issue of ordinary shares Capital expenditures included in accounts payable Capital expenditures included in accounts payable and accrued expenses Amount of asset retirement obligations. Asset Retirement Obligations Asset retirement obligation Amount of changes to right-of-use asset resulting from lease reassessment event. Changes to right-of-use asset resulting from lease reassessment event Changes to right-of-use asset resulting from lease reassessment event Nature of Business and Basis of Presentation Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block] Nature of Business and Basis of Presentation Summary of Significant Accounting Policies Significant Accounting Policies [Text Block] Summary of Significant Accounting Policies Foreign currency translation in General and Administrative Expenses Foreign Currency Disclosure [Text Block] Foreign currency translation in General and Administrative Expenses Net (Loss)/Income Per Share Earnings Per Share [Text Block] Net (Loss)/Income Per Share Property and equipment, net Property, Plant and Equipment Disclosure [Text Block] Property and equipment, net Intangible assets, net Intangible Assets Disclosure [Text Block] Intangible assets, net Prepaid expenses and other current assets The entire disclosure on prepaid expense and other current assets. Prepaid Expense and Other Assets, Current [Text Block] Prepaid expenses and other current assets Accrued expenses and other current liabilities The entire disclosure of the components of accrued liabilities and other current liabilities. Accrued Liabilities And Other Current Liabilities [Text Block] Accrued expenses and other current liabilities Ordinary Shares Stockholders' Equity Note Disclosure [Text Block] Ordinary Shares Deferred shares [Abstract] Deferred Shares The entire disclosure for Deferred Shares as disclosed by the entity. Stockholders Equity Deferred Shares Disclosure [Text Block] Deferred Shares Fair value Fair Value Disclosures [Text Block] Fair value Information about Goodwill. Goodwill. Goodwill Disclosure [Text Block] Goodwill Share-Based Compensation Share-based Payment Arrangement [Text Block] Share-Based Compensation Commitments and Contingencies Commitments and Contingencies Disclosure [Text Block] Commitments and Contingencies Related Party Transactions Related Party Transactions Disclosure [Text Block] Related Party Transactions Use of Estimates, Policy [Policy Text Block] Use of Estimates New Accounting Pronouncements, Policy [Policy Text Block] Recently issued accounting pronouncements Schedule of Earnings Per Share, Basic and Diluted [Table Text Block] Schedule of computation of basic and diluted net (loss)/income per share Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Table Text Block] Schedule of prepaid expenses and other current assets Tabular disclosure of the components of accrued liabilities and other current liabilities. Accrued Liabilities And Other Current Liabilities [Table Text Block] Schedule of accrued expenses and other current liabilities Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block] Schedule of financial instruments carried at fair value and classified within Level 3 Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table] Share-based Compensation Arrangement by Share-based Payment Award [Line items] Share-Based Compensation Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block] Schedule of fair value stock option issued to employees Share-based Payment Arrangement, Cost by Plan [Table Text Block] Schedule of share based compensation expense Tabular disclosure for Company's right-of-use asset and lease liability and other information. Lessee Operating Lease Right of Use asset and Other Information [Table Text Block] Schedule of right-of-use asset and a lease liability Lessee, Operating Lease, Liability, Maturity [Table Text Block] Schedule of future annual minimum lease payments under operating leases Foreign Currency Transaction Gain (Loss), before Tax Net foreign exchange gain (loss) Net Income (Loss) Attributable to Parent [Abstract] Numerator: Weighted Average Number of Shares Outstanding Reconciliation [Abstract] Denominator: Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount Shares excluded from the computation of diluted weighted-average shares outstanding Effect of dilutive stock options Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table] Antidilutive Securities [Axis] Antidilutive Securities, Name [Domain] Share-Based Payment Arrangement, Option [Member] Stock options Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] Antidilutive securities excluded from computation of earnings per share Property, Plant and Equipment [Table] Long-Lived Tangible Asset [Axis] Long-Lived Tangible Asset [Domain] Leasehold Improvements [Member] Leasehold improvements Property, Plant and Equipment [Line Items] Property and Equipment Property, Plant and Equipment, Additions Additions to property and equipment Depreciation Depreciation expense Schedule of Finite-Lived Intangible Assets [Table] Finite-Lived Intangible Assets by Major Class [Axis] Finite-Lived Intangible Assets, Major Class Name [Domain] Developed Technology [Member] Developed technology Finite-Lived Intangible Assets [Line Items] Intangible assets, net Finite-Lived Intangible Assets, Gross Intangible assets, gross Finite-Lived Intangible Assets, Accumulated Amortization Intangible assets, accumulated amortization Amortization of Intangible Assets Amortization expense for intangible assets The amount estimated amortization expense of intangible assets. Estimated Amortization Expense Of Intangible Assets Estimated annual amortization expense Prepaid Expense, Current Prepayments and accrued income Amount of employee retention and payroll tax credit, current as on the balance sheet date. Employee Retention And Payroll Tax Credit, Current Employee retention and payroll tax credit This item represents the current receivable for an incentive or inducement contractually stipulated between parties to a lease whereby the lessor has committed to provide the entity (lessee) with a cash payment as inducement to enter the lease. The receivable is due within one year. For classified balance sheets, this element represents the current amount receivable, that is amounts expected to be collected within one year or the normal operating cycle, if longer. Lease Incentive Receivables, Current Lease incentive receivable Other Assets, Current Others Carrying value as of the balance sheet date of obligations incurred through that date and payable for manufacturing and clinical expenses. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). Accrued Manufacturing and Clinical Expenses, Current Accrued manufacturing and clinical expenses Workers' Compensation Liability, Current Accrued board of director compensation Accrued Bonuses, Current Accrued bonus Accrued Employee Benefits, Current Accrued payroll and employee benefits Accrued Professional Fees, Current Accrued professional fees Amount of accrued leasehold improvements. Accrued Lease Hold Improvements Accrued leasehold improvements Other Accrued Liabilities, Current Accrued other Subsidiary or Equity Method Investee, Sale of Stock by Subsidiary or Equity Investee [Table] Sale of Stock [Axis] Sale of Stock [Domain] IPO [Member] IPO Subsidiary, Sale of Stock [Line Items] Ordinary Shares The number of votes that each common share is entitled. Common Stock Number of Votes Per Share Common shares, votes per share The minimum percentage of shares required to exercise preemptive rights. Percentage Of Shares Necessary To Exercise Preemptive Rights Percentage of ordinary shares present to exercise preemptive rights The period allowed to exercise preemptive rights. Period Of Preemptive Rights To Be Exercised Maximum period to exercise preemptive rights Schedule of Deferred shares. Deferred shares [Table] Represents information pertaining to deferred A shares. Deferred A Shares [Member] Deferred A Shares Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Deferred shares [Line items] Deferred Shares The amount of liquidation preference on ordinary shares to be paid after which the deferred shares have the entitlement to receive out of the assets of the Company. Ordinary Shares, Liquidation Preference Ordinary shares, liquidation preference Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table] Business Acquisition [Axis] Business Acquisition, Acquiree [Domain] This member stands for Avidea. Avidea. [Member] Avidea Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items] Convertible loan notes Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value Ending balance Beginning balance Contingent consideration liability Liability Class [Axis] Fair Value by Liability Class [Domain] Embedded Derivative Financial Instruments [Member] Embedded derivatives Fair Value Hierarchy and NAV [Axis] Fair Value Hierarchy and NAV [Domain] Level 3 Level 3 Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward] Fair value and classified within Level 3 Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings Change in fair value recognized in net (loss)/ income Amount of foreign exchange loss of financial instrument classified as a liability measured in fair value. Foreign Exchange Loss Foreign exchange loss Amount of foreign exchange translation of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing. Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Foreign Exchange Translation Foreign exchange translation recognized in other comprehensive loss Plan Name [Axis] Plan Name [Domain] Information pertaining to the Vaccitech plc Share Award Plan 2021. Vaccitech plc Share Award Plan 2021 [Member] Vaccitech plc Share Award Plan 2021 Information pertaining to the Enterprise Management Incentive Share Option Scheme. Enterprise Management Incentive Share Option Scheme [Member] Enterprise Management Incentive Share Option Scheme Award Type [Axis] Award Type [Domain] Employee Stock [Member] Stock option Information pertaining to aggregate awards under a specific share-based compensation plan. Restricted Share Units Stock Options Share Appreciation Rights And Restricted Shares [Member] Restricted share units, options, share appreciation rights and restricted shares Total number of shares available for issuance under the Plan as a percentage of the Company's issued and outstanding shares. Share-Based Compensation, Percentage Of Shares Available For Issuance As A Percentage Of Issued And Outstanding Shares Percentage of issued and outstanding ordinary shares available for issuance under the Plan Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures Options granted Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value Weighted-average grant date per-share fair value of stock options granted Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price Weighted average exercise price of options granted Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested Options Forfeited, Number of Shares Number of unvested options canceled Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number Exercise of stock options Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price Weighted average exercise price of options outstanding Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount Unrecognized compensation expenses related to options Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition Unrecognized compensation cost which is expected to be recognized over a weighted-average period Grantee Status [Axis] Grantee Status [Domain] Share Based Payment Arrangement Employee [Member] Employee Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate Expected volatility Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term Expected term (years) Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate Risk-free interest rate Income Statement Location [Axis] Income Statement Location [Domain] Research And Development Expense [Member] Research and development General And Administrative Expense [Member] General and administrative Share-based Payment Arrangement, Expense Share based compensation expense Other Commitments [Table] Statistical Measurement [Axis] Statistical Measurement [Domain] Maximum [Member] Maximum Minimum [Member] Minimum Collaborative Arrangement and Arrangement Other than Collaborative [Axis] Collaborative Arrangement and Arrangement Other than Collaborative [Domain] Represents the information pertaining to In-License Agreements. In-License Agreements [Member] In-License Agreements Geographical [Axis] Geographical [Domain] MD MARYLAND Balance Sheet Location [Axis] Balance Sheet Location [Domain] Other Non-current Assets Other Non-current Assets This member stands for Laboratory. Laboratory Laboratory Other Commitments [Line Items] Commitment and Contingencies Percentage of future royalties for direct sales of a covered product under the In-License Agreements. Percentage of Future Royalties for Direct Sales of Covered Product , License Agreement Percentage of future royalties for direct sales of a covered product Percentage of net payments received for allowable sublicenses of technology developed under the In-License Agreements. Percentage Of Net Payments Received For Allowable Sublicenses Of Technology Developed License Agreement Net payments received for allowable sublicenses of technology developed Represents the information pertaining to number of Square Feet Under Lease Agreement. Number Of Square Feet Under Lease Agreement Number of square feet under lease agreement Term of lessee's operating lease extended, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Lessee Operating Lease, Extended Term Additional lease term Leasehold Improvements, Gross Leasehold improvement expense Security Deposit Refundable security deposit Leases Leases Operating Lease, Weighted Average Remaining Lease Term Weighted average remaining lease term (years) Operating Lease, Weighted Average Discount Rate, Percent Weighted average discount rate Short-term Lease, Cost Short-term lease costs Operating Lease, Payments Operating cash flows from operating leases Future annual minimum lease payments under operating leases Amount of lessee's lease receivable for operating lease having initial or remaining lease term in excess of one year to be paid in remainder of current fiscal year. Lessee, Operating Lease, Receivable, Remainder of Fiscal Year Remainder of 2023 Lessee, Operating Lease, Liability, to be Paid, Year One 2024 Lessee, Operating Lease, Liability, to be Paid, Year Two 2025 Lessee, Operating Lease, Liability, to be Paid, Year Three 2026 Lessee, Operating Lease, Liability, to be Paid, Year Four 2027 Amount of lessee's undiscounted obligation for lease payment for operating lease due in year four and after fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach). Lessee, Operating Lease, Liability, to be Paid, after Year Four Thereafter Lessee, Operating Lease, Liability, to be Paid Total minimum lease payments Lessee, Operating Lease, Liability, Undiscounted Excess Amount Less: imputed interest Operating Lease, Liability Total operating lease liability Schedule of Related Party Transactions, by Related Party [Table] Related Party Transaction [Axis] Related Party Transaction [Domain] Represents the information pertaining to Lease of a laboratory and office space in Oxford. Lease of a laboratory and office space in Oxford Lease of a laboratory and office space in Oxford Represents the information pertaining to Clinical study costs. Clinical study costs Clinical study costs Related Party [Axis] Related Party [Domain] Represents the information pertaining to Shareholder of Oxford Sciences Innovation Plc. Shareholder of Oxford Sciences Innovation Plc Shareholder of Oxford Sciences Innovation Plc This member stands for Shareholder Of Oxford Sciences Enterprises Plc. Shareholder Of Oxford Sciences Enterprises Plc Shareholder Of Oxford Sciences Enterprises Plc Represents the information pertaining to Shareholder, the University of Oxford. Shareholder, the University of Oxford Shareholder, the University of Oxford Represents the information pertaining to Oxford University Innovation Limited. Oxford University Innovation Limited Oxford University Innovation Limited Related Party Transaction [Line Items] Related Party Transactions Related Party Transaction, Expenses from Transactions with Related Party Related party expenses Income from related party transactions. Income From Related Party Transactions Income from related party transactions Amount of refund received from related party. Refund Received From Related Party Refund received Due to Related Parties Due to related party